These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 623700)
21. Differential blockade by (-)mianserin of the alpha 2-adrenoceptors mediating inhibition of noradrenaline and serotonin release from rat brain synaptosomes. Raiteri M; Maura G; Gemignani A; Pittaluga A Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):180-2. PubMed ID: 6135160 [TBL] [Abstract][Full Text] [Related]
22. Blockade of presynaptic alpha-receptors and of amine uptake in the rat brain by the antidepressant mianserine. Baumann PA; Maître L Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):31-7. PubMed ID: 201871 [No Abstract] [Full Text] [Related]
23. The influence of mianserin and danitracen on the disappearance of noradrenaline in the rat brain. Klimek V; Mogilnicka E Pol J Pharmacol Pharm; 1978; 30(2-3):255-61. PubMed ID: 673929 [No Abstract] [Full Text] [Related]
24. Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes. Raiteri M; Angelini F; Bertollini A J Pharm Pharmacol; 1976 Jun; 28(6):483-8. PubMed ID: 7644 [TBL] [Abstract][Full Text] [Related]
25. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus. O'Connor WT; Leonard BE Neuropharmacology; 1986 Mar; 25(3):267-70. PubMed ID: 3703175 [TBL] [Abstract][Full Text] [Related]
26. [Prolonged administration of antidepressants induces changes in the pulsed release but not in the reverse uptake of biogenic amines]. Dolzhenko AT; Komissarov IV Biull Eksp Biol Med; 1986 May; 101(5):569-70. PubMed ID: 3708140 [TBL] [Abstract][Full Text] [Related]
27. Effects of quinupramine on the central monoamine uptake systems and involvement of pharmacokinetics in its pharmacological activities. Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K Jpn J Pharmacol; 1987 Oct; 45(2):169-75. PubMed ID: 3437586 [TBL] [Abstract][Full Text] [Related]
28. Proceedings: The effects of a new anti-depressant, ORG GB94, on amine uptake mechanisms. Goodlet I; Sugrue MF Br J Pharmacol; 1974 Nov; 52(3):431P. PubMed ID: 4458853 [No Abstract] [Full Text] [Related]
29. Proceedings: Effect of mianserin on noradrenaline uptake and release. Baumann PA; Maître L Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R3. PubMed ID: 1143416 [No Abstract] [Full Text] [Related]
30. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. Blackshear MA; Sanders-Bush E J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527 [TBL] [Abstract][Full Text] [Related]
31. Stress by forced swimming in the rat: effects of mianserin and moclobemide on GABAergic-monoaminergic systems in the brain. Cicardo VH; Carbone SE; de Rondina DC; Mastronardi IO Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 83(1):133-5. PubMed ID: 2869887 [TBL] [Abstract][Full Text] [Related]
32. Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat. Loew DM; Depoortere H; Buerki HR Arzneimittelforschung; 1976; 26(6):1080-3. PubMed ID: 822856 [TBL] [Abstract][Full Text] [Related]
33. Effect of mianserin hydrochloride on oxidative metabolism of rat brain in vitro. Dueñas Laita A; García Roldán JL; González Martínez de Zárate JL; Velasco-Martín A Farmaco Prat; 1983 Jun; 38(6):235-42. PubMed ID: 6309559 [No Abstract] [Full Text] [Related]
34. Reserpine causes biphasic nociceptive sensitivity alteration in conjunction with brain biogenic amine tones in rats. Oe T; Tsukamoto M; Nagakura Y Neuroscience; 2010 Sep; 169(4):1860-71. PubMed ID: 20600634 [TBL] [Abstract][Full Text] [Related]
35. Differential actions of mianserin and iprindole on the sensitivity of cortical neurons to noradrenaline: effect of chronic treatment. Olpe HR; Schellenberg A; Steinmann MW Eur J Pharmacol; 1981 Jul; 72(4):381-5. PubMed ID: 7274332 [TBL] [Abstract][Full Text] [Related]
36. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors. Gandolfi O; Barbaccia ML; Costa E J Pharmacol Exp Ther; 1984 Jun; 229(3):782-6. PubMed ID: 6327970 [TBL] [Abstract][Full Text] [Related]
37. Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state. Ahtee L; Attila LM; Carlson KR; Haikala H J Pharmacol Exp Ther; 1989 Apr; 249(1):303-10. PubMed ID: 2468763 [TBL] [Abstract][Full Text] [Related]
38. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain. Stancheva S; Grahovska T; Petkov VV Acta Physiol Pharmacol Bulg; 1985; 11(1):3-9. PubMed ID: 4036650 [TBL] [Abstract][Full Text] [Related]
39. [Pharmacological properties of MO-8282, a novel antidepressant]. Niho T; Ito C; Shibutani Y; Hashizume H; Yamaguchi K Nihon Yakurigaku Zasshi; 1986 Oct; 88(4):309-20. PubMed ID: 3792961 [TBL] [Abstract][Full Text] [Related]
40. Studies on brain metabolism of biogenic amines. Schacht U; Leven M; Bäcker G Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):77S-87S. PubMed ID: 199222 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]